Chemed (CHE) Revenue (2009 - 2026)

Chemed's Revenue history runs 18 years deep, the most recent figure standing at $657.5 million for Q1 2026.

• In Q1 2026, Revenue rose 1.63% year-over-year to $657.5 million; the TTM figure through Mar 2026 stood at $2.5 billion (up 2.07% YoY), while the FY2025 annual figure was $2.5 billion, up 4.06% from the prior year.
• Revenue was $657.5 million for Q1 2026 at Chemed, up from $639.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $657.5 million in Q1 2026 to a low of $526.5 million in Q3 2022.
• Historically, Revenue has averaged $589.3 million across 5 years, with a median of $589.2 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Revenue decreased 2.26% in 2022, then gained 9.79% in 2025.
• A 5-year view of Revenue shows it stood at $546.7 million in 2022, then climbed by 7.18% to $585.9 million in 2023, then increased by 9.23% to $640.0 million in 2024, then declined by 0.1% to $639.3 million in 2025, then rose by 2.84% to $657.5 million in 2026.
• The last three Revenue figures came in at $657.5 million (Q1 2026), $639.3 million (Q4 2025), and $624.9 million (Q3 2025), per Business Quant data.